Summary of altered tryptophan (Trp) metabolites is reported in autism spectrum disorder (ASD), attention-deficit/hyperactivity disorder (ADHD), Rett syndrome (RTT), and MeCP2 duplication syndrome. Here, MECP2 is linked to attention deficit-hyperactivity disorder.